Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial

被引:87
|
作者
Jones, RC [1 ]
Francis, GS [1 ]
Lauer, MS [1 ]
机构
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
关键词
D O I
10.1016/j.jacc.2004.05.077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES We identified predictors of mortality in patients with preserved ejection fraction (EF) and clinical heart failure (HF). BACKGROUND Although diastolic HF is common, the factors that predict mortality have not been clearly defined. METHODS We studied 988 patients with HF and preserved EF enrolled in the Digitalis Investigation Group (DIG) trial. Survival analyses were employed to identify variables associated with mortality. RESULTS During 3.1 years of follow-up, 231 (23%) patients died. Among 18 variables considered, the strongest independent predictors of death were glomerular filtration rate (adjusted hazard ratio for one standard deviation decrease 1.50, 95% confidence interval [CI] 1.35 to 1.67, p < 0.0001), New York Heart Association functional class III or TV (adjusted hazard ratio 1.64, 95% CI 1.20 to 2.18, p = 0.0011), male gender (adjusted hazard ratio 1.71, 95% CI 1.26 to 2.32, p = 0.0005), and older age (adjusted hazard ratio for one standard deviation increase of age 2 1.28, 95% Cl 1.08 to 1.50, p = 0.0019). A risk score was developed to estimate long-term mortality. CONCLUSIONS Diastolic HF is associated with a high death rate. Important predictors of death include impaired renal function, worse functional class, male gender, and older age. (C) 2004 by the American College of Cardiology Foundation.
引用
收藏
页码:1025 / 1029
页数:5
相关论文
共 50 条
  • [1] Predictors of mortality in patients with heart failure and preserved systolic function in the digitalis investigation group trial
    Jones, RC
    Blackstone, EH
    Francis, GS
    Lauer, MS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 219A - 219A
  • [2] Renal dysfunction is common in patients with heart failure and preserved systolic function: Retrospective analysis of the digitalis investigational group (DIG) trial
    Lee, CR
    Patterson, JH
    Gattis, WA
    Ghali, JK
    Shah, PJ
    Schwartz, TA
    Gheorghiade, M
    Adams, KF
    CIRCULATION, 2003, 108 (17) : 484 - 485
  • [3] Obesity and Mortality in Patients with Heart Failure and Preserved Systolic Function
    Kapoor, John R.
    Heidenreich, Paul A.
    CIRCULATION, 2008, 118 (18) : S795 - S795
  • [4] Prognosis predictors in heart failure with preserved systolic function
    Gouvea, E. P.
    Rocha, R. Mourilhe
    Albuquerque, D. C.
    Ferreira, A. G. M.
    Bittencourt, M. I.
    Oliveira, A. P.
    Esporcatte, R.
    Albanesi, F. M. Filho
    EUROPEAN HEART JOURNAL, 2005, 26 : 606 - 606
  • [5] Heart Rate Predicts Mortality in Patients With Heart Failure and Preserved Systolic Function
    Kapoor, John R.
    Heidenreich, Paul A.
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (10) : 806 - 811
  • [6] ULTRAFILTRATION IN HEART FAILURE PATIENTS WITH PRESERVED SYSTOLIC FUNCTION
    Chung, Eugene S.
    Menon, Santosh
    Bartone, Cheryl
    Akula, Nanandakishore
    Wagner, Jackie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [7] Heart failure in patients with preserved left ventricular systolic function: Do digitalis glycosides have a role?
    Massie, BM
    Abdalla, I
    PROGRESS IN CARDIOVASCULAR DISEASES, 1998, 40 (04) : 357 - 369
  • [8] Anemia in patients with heart failure and preserved systolic function
    Felker, GM
    Shaw, LK
    Stough, WG
    O'Connor, CM
    AMERICAN HEART JOURNAL, 2006, 151 (02) : 457 - 462
  • [9] Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function
    Shamagian, L. Grigorian
    Roman, A. Varela
    Garcia-Acuña, J. M.
    Ramos, P. Mazon
    Lamela, A. Virgos
    Gonzalez-Juanatey, J. R.
    HEART, 2006, 92 (06) : 780 - 784
  • [10] Heart failure with preserved systolic function
    Domanski M.
    Peyster E.
    Current Treatment Options in Cardiovascular Medicine, 2005, 7 (1) : 55 - 59